ENTRY       D11382            Mixture   Drug
NAME        Darunavir, cobicistat, emtricitabine and tenofovir alafenamide;
            Symtuza (TN)
PRODUCT     SYMTUZA (Janssen Products LP)
COMPONENT   (Darunavir [DR:D03656] | Darunavir ethanolate [DR:D06478]), Cobicistat [DR:D09881], Emtricitabine [DR:D01199], (Tenofovir alafenamide [DR:D10428] | Tenofovir alafenamide fumarate [DR:D10605])
CLASS       Antiviral
             DG03107  Anti-HIV agent
REMARK      Therapeutic category: 6250
            ATC code: J05AR22
            Product: D11382<JP/US>
EFFICACY    Antiviral
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV protease [KO:K22599]
            HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K22599+K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K22599+K24802)  Viral life cycle - HIV-1
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AR Antivirals for treatment of HIV infections, combinations
                 J05AR22 Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
                  D11382  Darunavir, cobicistat, emtricitabine and tenofovir alafenamide &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Combinations
               Darunavir/ Cobicistat/ Emtricitabine/ Tenofovir Alafenamide Fumarate
                D11382  Darunavir, cobicistat, emtricitabine and tenofovir alafenamide
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D11382  Darunavir, cobicistat, emtricitabine and tenofovir alafenamide
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               D11382  Darunavir, cobicistat, emtricitabine and tenofovir alafenamide
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D11382  Darunavir, cobicistat, emtricitabine and tenofovir alafenamide
            Antimicrobials [BR:br08307]
             Antivirals
              Polyprotein cleavage inhibitor
               HIV protease inhibitor
                D11382  Darunavir, cobicistat, emtricitabine and tenofovir alafenamide &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11382
DBLINKS     PubChem: 384585360
///
